(Just click the link below)

SS1 - Inform

SS2 - Newborn Screening

SS3 - Homocystinuria

SS4 - Nutrition and Dietetics

Sponsorship Opportunities

The ICIEM 2017 is prepared to receive over 2,000 delegates from 50+ different countries in an exhibition area with 51 booths distributed in 663 m2.

In addition, we will have 24 opportunities for sponsored satellite symposium that will happen at breakfast and lunch times, in 4 simultaneous rooms. This activity offers the opportunity to provide attendees with comprehensive insights into important research topics and issues of your product.

We also offer the possibility of your company having an exclusive room for meetings during the whole event, which we call business suites. There are 5 rooms with capacities from 24 to 100 people.

ICIEM 2017 follows Brazilian and international compliance regulations. Corporate sponsorship will not be used to support social activities, and corporate logos or corporate promotional materials will not be displayed in any social activity.

The Exhibitor and Sponsorship Prospectus is available by request via email to

Confirmed Sponsors










Sponsored Symposia


  • Oceania 01 - VITAFLO
  • Symposium Title - Glycomacropeptide through the lifespan of Phenylketonuria: The story unfolds

    Speakers: Prof. Anita MacDonald (Consultant in clinical IMD, Birmingham Children’s Hospital, UK); Charlotte Ellerton (Senior Metabolic Dietitian, National Hospital for Neurology and Neurosurgery, London, UK); Louise Robertson (Specialist Dietitian in IMD - Adults. Queen Elizabeth Hospital Birmingham, UK)

  • SPONSORED LUNCH SYMPOSIA (12:45 to 13:45)
  • Oceania 01 – AMICUS
  • Symposium Title – Chaperone therapy: a new paradigm in Fabry disease.
    Chairman: Hernan Amartino, MD, Head of Child Neurology Department, Hospital Universitario Austral, Buenos Aires, Argentina

    12:45 - 12:55 – Welcome/Introduction from Chair
    Speaker: Hernan Amartino, MD (Chair)

    12:55 - 13:15 – Chaperone therapy: a new paradigm in Fabry disease
    Speaker: Dominique Germain, MD, PhD, Head of Division of Medical Genetics, Raymond Poincare Hospital, Garches, France

    13:15 - 13:35 – The safety and efficacy of migalastat in Phase 3 clinical trials and long term extension studies
    Speaker: Ulla Feldt-Rasmussen, MD, DMSc, Chief of Medical Endocrinology, Copenhagen University Hospital, Copenhagen, Denmark

    13:35 - 13:45 - Panel Discussion and Q&A
    Faculty & Audience.

  • Oceania 02 - BIOMARIN
  • Symposium Title - Expediting Diagnosis when it Matters Most – New Data for Managing Children with CLN2 Disease.

    12:45-12:50 - Welcome and Introduction
    Speaker: Carolina Fischinger Moura de Souza, MD, PhD Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil

    12:50 - 13:10 - CLN2 Natural History and New Clinical Data
    Speaker: Marina Trivisano, MD, PhD Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

    13:10 - 13:35 - Insights for Early Identification and Management of CLN2
    Speaker: Norberto Guelbert, MD, PhD - Hospital de Niños de Córdoba, Córdoba, Argentina

    13:35 - 13:45 - Panel Discussion
    Faculty & Audience.

  • Oceania 03 - SOBI
  • Symposium Title – In search of the optimal patient journey in tyrosinemia type 1 - treatment guidance and advancements in understanding neurocognitive outcomes

    Chairman: Maria Ignacia García (INTA, University of Chile, Santiago, Chile)

    12:45 - 12:50 - Introduction by Chairman

    12:50 - 13:05 - Tyrosinemia type I – Recommendations for diagnosis and treatment
    Speaker: Jeffrey Chinsky (Johns Hopkins University School of Medicine, Baltimore, USA)

    13:05 - 13:20 - Cognitive Functioning in tyrosinemia type I patients and clinical experience in Chile
    Speaker: Maria Ignacia García (INTA, University of Chile, Santiago, Chile)

    13:20 - 13:35 - Mechanisms for cognitive and behavioral effects of tyrosinemia type I
    Speaker: Gordon MacGregor (University of Alabama, Huntsville, USA)

    13:35 - 13:45 - Question and final remarks by Chairman

  • Oceania 04 - SHIRE
  • Symposium Title - Blood–brain barrier in MPS: Old challenges and new strategies

    12:45 - Welcome and introductions
    Chair: Prof. Maurizio Scarpa (Germany)

    12:50 - Physiology and pathophysiology of the blood–brain barrier
    Speaker: Dr. David Begley (UK)

    13:05 - Intrathecal delivery of biologics to the brain
    Speaker: Asst. Prof. Robert G.Thorne (USA)

    13:20 - Delivery of macromolecules to the brain in MPS patients
    Speaker: Prof. Maurizio Scarpa (Germany)

    13:35 - Audience Q&A

    13:40 - Summary and close
    Chair: Prof. Maurizio Scarpa (Germany)


  • Oceania 01 – SANOFI-GENZYME
  • Symposium Title – Fabry disease: Genotype/phenotype correlations, diagnostic dilemmas and treatment decisions

    7:15 – Genotype/phenotype correlations and diagnostic dilemmas
    Speaker: Dr Robert J. Denisck (The Mount Sinai Hospital, New York, USA)

    7:55 – Treatment Decisions: Who to treat, when, how and why
    Speaker: Dr. Alberto Ortiz (Jimenez Dias Foundation, Madrid, Spain)

    8:35 – Questions & Answers

  • Oceania 02 – BIOMARIN
  • Overall title: PKU: Evolving treatment strategies – Experience from across the globe

    Co-Chairs: Jerry Vockley, MD, PhD, Pittsburgh, PA, USA & Paula Vargas, MD, PhD, Porto Alegre, RS, Brazil

    07:30 - 07:45 - PKU overview across the globe
    Speaker: Paula Vargas, MD, PhD (Hospital Materno Infantil Presidente Vargas, Porto Alegre, RS, Brazil)

    07:45 - 08:00 - Phe levels: evolving clinical focus based on emerging data
    Speaker: H. Serap Sivri, MD (Department of Pediatrics, Nutrition & Metabolism Unit, Hacettepe University Children’s Hospital, Ankara, Turkey)

    08:00 - 08:15 - Clinical consequences of high Phe levels: a case study
    Speaker: Mina D. Nguyen-Driver, PsyD (Oregon Health and Science University, Institute on Development and Disability, Portland, OR, USA)

    08:15 - 08:35 - Phe targets, current guidelines and evolving thinking
    Speaker: Jerry Vockley, MD, PhD (Children’s Hospital of Pittsburgh and University of Pittsburgh, Pittsburgh, PA, USA)

    08:35 - 08:45 - Discussion
    Faculty & Audience

  • Oceania 03 - CENTOGENE
  • Symposium Title: Metabolics meets Genetics - only the combination brings the solution to our patients

    07:15 – 07:40 - Complexity in the clinical and laboratory diagnosis in patients with metabolic diseases
    Speaker: Prof. Arndt Rolfs (CEO, CENTOGENE AG, Rostock, Germany)

    07:40 – 08:00 - Metabolic diseases - the importance of biomarkers
    Speaker: Dr. Claudia Cozma (Senior Director HTS, CENTOGENE AG, Rostock, Germany)

    08:00 – 08:20 - The value of worldwide mutation databases in metabolic diseases
    Speaker: Alekhya Narravula (Certified Genetic Counselor, Medical Affairs Manager, CENTOGENE AG, Rostock, Germany)

    08:20 – 08:35 - Clinical workflows and procedures to identify metabolic patients much earlier
    Speaker: Prof. Arndt Rolfs (CEO, CENTOGENE AG, Rostock, Germany)

    08:35 – 08:45 – Q&A

  • Oceania 04 - NUTRICIA
  • Symposium Title - PKU and NUTRITION – The successful journey continues

    07:15 – 07:20 – Welcome

    07:20 – 07:40 – The extraordinary success of dietary treatment in severe phenylalanine hydroxylase deficiency
    Speaker: Prof John Walter (United Kingdom)

    07:40 – 08:00 – The challenge of a relaxed PKU diet: Nutritional habits and micronutrient supply
    Speaker: Dr. Skadi Beblo (Germany)

    08:00 – 08:20 – Phenylketonuria – pathogenesis of multidirectional phenylalanine neurotoxicity
    Speaker: Prof Maria Gizewska (Poland)

    08:20 – 08:30 – Q&A


  • Oceania 01 – SANOFI-GENZYME
  • Symposium Title: The Future of Gaucher Disease Management

    07:15 – 07:20 - Opening Remarks
    Speaker: Dr. Ana Maria Martins, MSc, PhD (IGEIM Federal University of São Paulo, São Paulo, Brazil)

    07:20 – 07:40 - Pioneers in Innovative Management of Gaucher Disease
    Speaker: Dr. Ana Maria Martins, MSc, PhD (IGEIM Federal University of São Paulo, São Paulo, Brazil)

    7:40 – 7:45 - Questions

    7:45 – 8:05 - Bone Manifestations in Gaucher Disease
    Speaker: Dr. Jose Simon Camelo Jr., MSc, PhD (São Paulo University, Ribeirão Preto, Brazil)

    8:05 – 8:10 - Questions

    8:10 – 8:30 - Oral SRT for the Treatment of Gaucher Disease Type 1 Patients
    Speaker: Dr. Alexandre Nonino, MD (Hospital de Base do Distrito Federal, Brasilia – DF, Brazil)

    8:30 – 8:35 - Questions

    8:35 – 8:45 - Closing Remarks
    Speaker: Dr. Ana Maria Martins, MSc, PhD (IGEIM, Federal University of São Paulo, São Paulo, Brazil)

  • Oceania 03 – METABOLON
  • Symposium Title: Metabolomics – Bringing Answers to IEM and other Difficult Diagnoses

    Speakers: Sandra Merkel-DeJames (Ph.D. - Vice President, Precision Medicine, North Carolina, United States); Adam Kennedy (Ph.D. – Director, Scientific Discovery and Application, North Carolina, United States)

  • Oceania 04 – SHIRE
  • Symposium Title – Long-term outcomes of enzyme replacement in LSDs

    Speakers: Prof. Roberto Giugliani, Chair (Brazil); Hartmann Wellhoefer (Switzerland); Dr Hernan Amartino (Argentina); Prof. Ari Zimran (Israel); Dr Uma Ramaswami (UK)

  • SPONSORED LUNCH SYMPOSIA (12:45 to 13:45)
  • Oceania 01 – SANOFI-GENZYME
  • Symposium Title – Newborn Screening for Lysosomal Storage Diseases

    12:45 – Overview of NBS Programs for LSDs
    Speaker: Dr. R. Rodney Howell (Miller School of Medicine University of Miami, Miami, USA)

    12:55 – NBS for Pompe Disease: Learnings from the Past 10+ Years.
    Speaker: Dr. Paul Hwu (National Taiwan University Hospital, Taipei, Taiwan)

    13:15 – NBS for MPS I: Algorithm for Two – Tier Screening
    Speaker: Dr. Francyne Kubaski (Hospital de Clinicas de Porto Alegre, Rio Grande do Sul, Brazil)

    13:35 – Questions & Closing Remarks
    Speaker: Dr. R. Rodney Howell (Miller School of Medicine University of Miami, Miami, USA)

  • Oceania 02 – BIOMARIN
  • Overall title: MPS diagnostic odyssey: Speeding time to diagnosis
    Chair: Roberto Giugliani, MD, PhD (Porto Alegre, RS, Brazil)

    12:45 - 12:55 - Introduction: The need for earlier diagnosis
    Speaker: Roberto Giugliani, MD, PhD (Porto Alegre, RS, Brazil 12:55-13:10 - My family’s journey to an MPS diagnosis)

    12:55 - 13:10 - My family’s journey to an MPS diagnosis
    Speaker: Jennifer B. Kau, RN, BSN (Santa Clara, CA, USA)

    13:10 - 13:35 - MPS: The race to early diagnosis
    Speaker: Frits A. Wijburg, MD, PhD (Amsterdam, The Netherlands)

    13:35 - 13:45 – Discussion
    Faculty & Audience.

  • Symposium Title: STABILISE. RATIONALISE. OPTIMISE. Exploring long-term therapy options for hyperammonaemia in organic acidaemias
    Chair: Prof Dr Johannes Häberle (University Children's Hospital, Zurich, Switzerland)

    12:45 – 12:50 - Welcome, introductions and objectives
    Speaker: Prof Dr Johannes Häberle

    12:50 – 13:00 - Methylmalonic and propionic acidaemia, with the possible causes of hyperammonaemia: An overview of pathophysiology and biochemistry
    Speaker: Prof Dr Nicholas Ah Mew

    13:05 – 13:15 - Comparing short and long-term outcomes/complications of hyperammonaemia in patients treated with long term vs other management strategies
    Speaker: Prof Dr Nicola Longo

    13:20–13:45 Strategies for hyperammonaemia including experiences with long-term treatment (Presentation, discussion and debate, including Q+A)
    Speaker: Prof Dr Sufin Yap & Dr Ana Moráis López

    Debate chaired by Johannes Häberle

  • Room Oceania 04 - ALEXION
  • Symposium Title: Clinical Implications of Complex Genetics - Evolving Evidence and Case Examples in Hypophosphatasia (HPP)
    Chair: Ana Maria Martins, MD, PhD (Professor of Pediatrics Universidade Federal de São Paulo, São Paulo, Brazil)

    12:45 – 12:50 - Welcome and Introductions
    Speaker: Profa Dr. Ana Maria Martins

    12:50 – 13:00 - HPP: Overview
    Speaker: Profa Dr. Ana Maria Martins

    13:00 – 13:20 - HPP Case Reports 1 and 2
    Speaker: Profa Dr. Ana Maria Martins

    13:20 – 13:40 - HPP Case Reports 3 and 4
    Speaker Dr. Juan Carlos Prieto

    13:40 – 13:45 - Conclusion and Q&A
    Speaker: Profa Dr. Ana Maria Martins

    To register please click here: